USPTO grants another CRISPR patent to Charpentier

The US Patent and Trademark Office (USPTO) has issued a third CRISPR patent to inventor Emmanuelle Charpentier, one of the key figures in the CRISPR landscape.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotechnology

EPO grants eukaryotic cell CRISPR patent to Charpentier

4 April 2019 The European Patent Office has issued a new CRISPR/Cas9 patent to inventor Emmanuelle Charpentier, one of the key figures in the CRISPR landscape.

Americas

USPTO grants Charpentier-founded company first CRISPR patent

20 June 2018 The US Patent and Trademark Office has granted ERS Genomics its first US patent covering the use of CRISPR/Cas9 technology for gene editing.

Europe

EPO grants second CRISPR patent to ERS Genomics

7 March 2018 The European Patent Office has granted a second CRISPR/Cas9 patent to a specialist genomics company, one month after revoking the Broad Institute of Harvard and MIT’s patent relating to the technology.

More on this story

Biotechnology

EPO grants eukaryotic cell CRISPR patent to Charpentier

4 April 2019 The European Patent Office has issued a new CRISPR/Cas9 patent to inventor Emmanuelle Charpentier, one of the key figures in the CRISPR landscape.

Americas

USPTO grants Charpentier-founded company first CRISPR patent

20 June 2018 The US Patent and Trademark Office has granted ERS Genomics its first US patent covering the use of CRISPR/Cas9 technology for gene editing.

Europe

EPO grants second CRISPR patent to ERS Genomics

More on this story

Biotechnology

EPO grants eukaryotic cell CRISPR patent to Charpentier

4 April 2019 The European Patent Office has issued a new CRISPR/Cas9 patent to inventor Emmanuelle Charpentier, one of the key figures in the CRISPR landscape.

Americas

USPTO grants Charpentier-founded company first CRISPR patent

20 June 2018 The US Patent and Trademark Office has granted ERS Genomics its first US patent covering the use of CRISPR/Cas9 technology for gene editing.

Europe

EPO grants second CRISPR patent to ERS Genomics